Drug Profile
Research programme: anticancer therapeutics - Meridian Lab
Alternative Names: Captisol-enabled® taxotere; ML-141Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Meridian Lab
- Class Small molecules; Taxanes
- Mechanism of Action Mitosis inhibitors; Tubulin inhibitors; Tubulin polymerisation promoters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer